KZR
|
Kezar Life Sciences, Inc.
|
0.05%
|
US
|
NASDAQ
|
MXCT
|
Maxcyte Inc
|
0.04%
|
UK
|
LSE
|
TCDA
|
Tricida, Inc.
|
0.04%
|
US
|
NASDAQ
|
SEER
|
Seer, Inc.
|
0.04%
|
US
|
NASDAQ
|
RPTX
|
Repare Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
PETQ
|
PetIQ, Inc.
|
0.04%
|
US
|
NASDAQ
|
MRSN
|
Mersana Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
MCRB
|
Seres Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
KNTE
|
Kinnate Biopharma Inc.
|
0.04%
|
US
|
NASDAQ
|
JANX
|
Janux Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
IMVT
|
Immunovant, Inc.
|
0.04%
|
US
|
NASDAQ
|
IMGO
|
Imago BioSciences, Inc
|
0.04%
|
US
|
NASDAQ
|
IMAB
|
I-Mab
|
0.04%
|
US
|
NASDAQ
|
IGMS
|
IGM Biosciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
EWTX
|
Edgewise Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
CRBU
|
Caribou Biosciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
CDXS
|
Codexis, Inc.
|
0.04%
|
US
|
NASDAQ
|